Stockreport

Summit Therapeutics (SMMT) Is Down 8.7% After Ivonescimab BLA Filing And Oncology Expansion Update – Has The Bull Case Changed? [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF with chemotherapy for previously treated EGFR-mutated non-squamous non-small cell lung cancer, supported by Phase III HARMONi trial data and multiple ongoing global stud [Read more]